Vaccine Packaging Market Size & Share 2024 to 2032
Market Size by Product, by Type, by Material, by End Use & Forecast.
Report ID: GMI11929
|
Published Date: October 2024
|
Report Format: PDF
Download Free PDF
Authors:
Suraj Gujar, Sandeep Ugale
Vaccine Packaging Market Size
The global vaccine packaging market was valued at USD 1.8 billion in 2023 and is estimated to grow at a CAGR of 10.4% from 2024 to 2032.
Vaccine Packaging Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
The vaccine packaging industry is experiencing growth due to several key factors. Global vaccination initiatives, supported by governments and health organizations, are increasing demand for advanced packaging solutions. These solutions must ensure vaccine safety, efficacy, and compliance with strict regulatory standards. Technological advancements in packaging materials, including smart packaging with monitoring capabilities, are improving vaccine integrity during storage and distribution.
The rise of biologics and complex vaccines requires specialized packaging designs for stability and extended shelf life. Sustainability concerns are influencing the market, with a focus on eco-friendly materials and waste reduction. The COVID-19 pandemic has highlighted the importance of efficient and scalable vaccine packaging solutions, leading to accelerated innovation and market expansion to meet increased healthcare needs. For instance, January 2024, SCHOTT Pharma launched the EVERIC freeze vials, specifically designed for the deep-cold storage of pharmaceuticals, including mRNA vaccines and gene therapies. These vials can withstand storage temperatures as low as -80°C, addressing the challenges posed by the freezing and thawing processes that often lead to glass breakage in conventional vials.
Vaccine Packaging Market Trends
The vaccine packaging industry is evolving rapidly, driven by new technologies and changing healthcare needs. Single-dose formats are gaining popularity, offering convenience and reducing waste in mass immunization programs. High-performance plastics like cyclic olefin polymers are replacing traditional glass containers, providing durability and design flexibility. Smart packaging with RFID tags and temperature sensors ensures vaccine integrity throughout the supply chain. The market is growing significantly in emerging regions like Asia Pacific and Latin America, where expanding healthcare infrastructure and increased government investment create new opportunities. These areas face unique challenges in vaccine delivery to diverse populations, making improved cold chain logistics and modern packaging solutions essential for safe distribution, even to remote locations.
Vaccine Packaging Market Analysis
The vaccine packaging industry faces several challenges, including strict regulations, high costs, and complex temperature control needs. These factors, along with material shortages and supply chain issues, create barriers for new entrants and operational hurdles for existing players. However, the market also offers significant opportunities. Growing immunization programs worldwide, especially in developing countries, presents expansion potential. Advances in smart packaging, such as temperature monitoring and anti-counterfeiting features, open new revenue streams. The rise of biological drugs, increased demand for prefilled syringes, and a shift towards sustainable materials further drive growth. Additionally, the development of innovative vaccine delivery systems provides promising avenues for market expansion and technological progress.
Based on type the market is segmented into primary packaging, secondary packaging, and tertiary packaging. The primary packaging segment dominate the market with a revenue share of over 52% in 2023.
Based on material, the market is segmented into glass, plastics, and metals. The plastics segment is projected to grow at a CAGR of over 11% and is expected to reach over USD 1 billion by 2032.
North America market held a significant share of over 35% in 2023 in the global vaccine packaging market. The U.S. market is a key part of the global industry, with strict rules and a strong healthcare system. It focuses on quality and FDA compliance, driving new packaging ideas. As the U.S. expands vaccination efforts and prepares for future health crises, companies have chances to create better packaging that keeps vaccines safe and easy to transport.
India's vaccine packaging industry is booming, fueled by the country's role as a major vaccine producer and exporter. Government programs, a strong pharmaceutical industry, and pandemic preparedness efforts are driving demand for better packaging solutions. As healthcare and biotech sectors grow, there's an increasing need for innovative packaging, especially for vaccines that need careful temperature control.
China's vaccine packaging market is booming, driven by its expanding pharmaceutical sector and focus on domestic vaccine production. As a major global vaccine manufacturer, China faces growing demand for advanced packaging solutions. This trend aligns with the country's efforts to improve public health and fight infectious diseases. The government is investing in smart packaging technologies, like RFID tags and temperature monitors, to enhance cold chain logistics and maintain vaccine quality. China's large-scale immunization programs and vast population create opportunities for packaging manufacturers to innovate in this highly regulated healthcare landscape.
The UK market boasts a strong healthcare system and strict rules. As a key player in Europe's vaccine scene, the UK focuses on packaging that keeps vaccines safe and effective. The country's solid cold chain network supports special packaging needs, especially for delicate vaccines like COVID-19 shots. The UK is also investing in new tech, such as smart packaging that tracks temperature, to keep vaccines in top shape. At the same time, there's a push for eco-friendly options that still meet all the rules. This blend of safety, innovation, and sustainability is shaping the UK's approach to vaccine packaging.
Vaccine Packaging Market Share
The vaccine packaging industry is led by a few major global players, each with unique strengths to meet industry demands. Key competitors include Becton Dickinson, Schott, Gerresheimer, Nipro, Amcor, West Pharmaceutical Services, and Corning. These companies compete on their expertise in advanced packaging materials, smart packaging innovations, and regulatory compliance capabilities. They aim to gain market share by offering diverse portfolios for various vaccine types and delivery systems, while focusing on sustainability and cost-effectiveness. The market is shaped by strategic partnerships, mergers, acquisitions, and R&D investments as companies strive to maintain their positions and capitalize on global vaccination opportunities.
Vaccine Packaging Market Companies
Major players operating in the vaccine packaging industry are:
Vaccine Packaging Industry News
This vaccine packaging market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Million) from 2021 to 2032, for the following segments:
Click here to Buy Section of this Report
Market, By Product
Market, By Type
Market, By Material
Market, By End Use
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →